Cases & Deals

Truffle Capital forms Truffle BioMedTech Crossover Fund

Clients Truffle Capital SAS

Jones Day represented Truffle Capital SAS in connection with the formation and fundraising of Truffle BioMedTech Crossover Fund, a €85 million (US$102 million) medical device and biotechnology venture fund that aims to close at €200 million later in 2018.